These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17210154)

  • 1. Atherosclerosis risk factors in children of parents with the metabolic syndrome.
    Akinci G; Coskun S; Akinci B; Hekimsoy Z; Bayindir P; Onur E; Ozmen B
    Atherosclerosis; 2007 Oct; 194(2):e165-71. PubMed ID: 17210154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
    Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
    Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum resistin levels with metabolic syndrome and early atherosclerosis in obese Chinese children.
    Chen XY; Zhang JH; Liu F; Liu HM; Song YY; Liu YL
    J Pediatr Endocrinol Metab; 2013; 26(9-10):855-60. PubMed ID: 23729554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased inflammatory markers in children with familial hypercholesterolaemia.
    Ueland T; Vissers MN; Wiegman A; Rodenburg J; Hutten B; Gullestad L; Ose L; Rifai N; Ridker PM; Kastelein JJ; Aukrust P; Semb AG
    Eur J Clin Invest; 2006 Mar; 36(3):147-52. PubMed ID: 16506958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.
    Kressel G; Trunz B; Bub A; Hülsmann O; Wolters M; Lichtinghagen R; Stichtenoth DO; Hahn A
    Atherosclerosis; 2009 Jan; 202(1):263-71. PubMed ID: 18501910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD40 ligand levels in otherwise healthy subjects with impaired fasting glucose.
    Tasci I; Dogru T; Sonmez A; Genc H; Kilic S; Olgun A; Gok M; Erdem G; Erikci S
    Mediators Inflamm; 2006; 2006(5):32508. PubMed ID: 17392573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.
    Genc H; Dogru T; Tapan S; Tasci I; Bozoglu E; Gok M; Aslan F; Celebi G; Erdem G; Avcu F; Ural AU; Sonmez A
    Clin Biochem; 2012 Jan; 45(1-2):92-5. PubMed ID: 22100896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease.
    Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W
    Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
    Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
    Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people.
    Unek IT; Bayraktar F; Solmaz D; Ellidokuz H; Sisman AR; Yuksel F; Yesil S
    Clin Med Res; 2010 Jul; 8(2):89-95. PubMed ID: 20660932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower birth weight predicts metabolic syndrome in young adults: the Atherosclerosis Risk in Young Adults (ARYA)-study.
    Ramadhani MK; Grobbee DE; Bots ML; Castro Cabezas M; Vos LE; Oren A; Uiterwaal CS
    Atherosclerosis; 2006 Jan; 184(1):21-7. PubMed ID: 16326169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could mean platelet volume among complete blood count parameters be a surrogate marker of metabolic syndrome in pre-pubertal children?
    Aypak C; Türedi O; Bircan MA; Yüce A
    Platelets; 2014; 25(6):393-8. PubMed ID: 23972029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.
    González AS; Guerrero DB; Soto MB; Díaz SP; Martinez-Olmos M; Vidal O
    Eur J Clin Nutr; 2006 Jun; 60(6):802-9. PubMed ID: 16493453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men.
    Fu CP; Sheu WH; Lee IT; Tsai IC; Lee WJ; Liang KW; Lee WL; Lin SY
    Clin Chim Acta; 2013 Jun; 421():98-103. PubMed ID: 23499571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
    El-Mesallamy HO; Abd El-Razek RS; El-Refaie TA
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):178-82. PubMed ID: 23434327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism.
    Akinci B; Comlekci A; Yener S; Demir T; Bayraktar F; Yuksel F; Yesil S
    Hormones (Athens); 2007; 6(4):327-33. PubMed ID: 18055424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.